Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response.
Novartis
Novartis
Takeda
Cogent Biosciences, Inc.
Celgene
AbbVie
Jazz Pharmaceuticals
Hoffmann-La Roche
Teva Branded Pharmaceutical Products R&D, Inc.
Jiangsu HengRui Medicine Co., Ltd.
Teva Branded Pharmaceutical Products R&D, Inc.
Antisoma Research
Amgen